Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study.
Iughetti L, Antoniazzi F, Giavoli C, Bellone S, Aversa T, Guazzarotti L, Street ME, Miraglia Del Giudice E, Persani L, Pozzobon G, Ragusa L, Stagi S, Tornese G, Zecchino C, Mameli C, Zecchi E, Fedeli P, Zabransky M, Lucaccioni L, Zucchini S.
Iughetti L, et al. Among authors: zucchini s.
Endocrine. 2024 Nov 29. doi: 10.1007/s12020-024-04090-x. Online ahead of print.
Endocrine. 2024.
PMID: 39612101
Review.